The Patent Finder

RSV F Protein Compositions and Method for Making Same

GlaxoSmithKline Biologicals S.A.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application 12/836,931, filed Jul 15, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 11,629,181RSV F Protein Compositions and Methods for Making Same
In force
 · Medium confidence
UsedRemaining
GlaxoSmithKline Biologicals S.A.In forceMedium confidence
US 11,655,284RSV F Protein Compositions and Methods for Making Same
In force
 · Low confidence
GlaxoSmithKline Biologicals S.A.In forceLow confidence
US 11,820,812RSV F Protein Compositions and Methods for Making Same
In force
 · High confidence
GlaxoSmithKline Biologicals S.A.In forceHigh confidence
US 11,827,694RSV F Protein Compositions and Methods for Making Same
In force
 · High confidence
GlaxoSmithKline Biologicals S.A.In forceHigh confidence
US 11,261,239RSV F Protein Compositions and Method for Making Same
In force
 · High confidence
GlaxoSmithKline Biologicals S.A.In forceHigh confidence
Application 12/836,931RSV F Protein Compositions and Methods for Making Same
Abandoned
Abandoned Aug 30, 2017
GlaxoSmithKline Biologicals S.A.AbandonedAbandoned Aug 30, 2017
Application 18/323,166RSV F Protein Compositions and Methods for Making Same
Abandoned
Abandoned Jun 12, 2025
GlaxoSmithKline Biologicals S.A.AbandonedAbandoned Jun 12, 2025
Application 18/323,177RSV F Protein Compositions and Methods for Making Same
Abandoned
Abandoned Jul 25, 2025
GlaxoSmithKline Biologicals S.A.AbandonedAbandoned Jul 25, 2025
Application 18/323,185RSV F Protein Compositions and Methods for Making Same
Abandoned
Abandoned Aug 9, 2025
GlaxoSmithKline Biologicals S.A.AbandonedAbandoned Aug 9, 2025
Application 18/323,192RSV F Protein Compositions and Methods for Making Same
Abandoned
Abandoned Jun 5, 2025
GlaxoSmithKline Biologicals S.A.AbandonedAbandoned Jun 5, 2025
2 more records in this group · Pro
10 of 12 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 12.
Upgrade to Pro
5 of these are in force and held by GlaxoSmithKline Biologicals S.A..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited